Open AccessTreatment of idiopathic membranoproliferative glomerulonephritis with mycophenolate mofetil and steroids
Author(s) -
Gareth Jones,
Maciej Juszczak,
Edward Kingdon,
Mark Harber,
P. Sweny,
A. Burns
Publication year - 2004
Publication title -
nephrology dialysis transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.654
H-Index - 168
eISSN - 1460-2385
pISSN - 0931-0509
DOI - 10.1093/ndt/gfh526
Subject(s) - medicine , mycophenolate , membranoproliferative glomerulonephritis , glomerulonephritis , dermatology , transplantation , kidney
Treatment of adults with idiopathic membranoproliferative glomerulonephritis (IMPGN) is often unrewarding with approximately 60% of patients progressing to end-stage renal failure within 10 years. Although children with IMPGN may respond to steroid therapy, there is no significant benefit to treating adult IMPGN patients with immunosuppression.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom